Based on bioinformatics analysis, the Pluslife Mini Dock can effectively detect the new Omicron coronavirus sub-variant known as BA. 2, and laboratory verification is still in progress.

Since 2020, Pluslife's coronavirus detection methods have continued to provide strong support for the global fight against the epidemic. Pluslife will keep its efforts to the genetic mutation of the new sub-variants of coronavirus in the world, attaches great importance to the nucleic acid detection of the new variants, and continues to track, evaluate and verify the capabilities of our products in order to cope with future challenges.

The Covid Omicron BA. 2, is the newest descendant of the omicron variant which responsible for huge surges of covid-19 in the United States and elsewhere around the globe. As the highly contagious omicron BA. 2 variant of the coronavirus spreads in parts of Asia, Europe, and North America, the World Health Organization recommended that officials begin investigating its characteristics to determine whether it poses new challenges for pandemic-weary nations.

Globally, a total of 8,040 sequences of BA.2 have been uploaded to the global variant database Gisaid since 17 November 2021.